-Screening of 238 compounds (24 h). Measurement of viability and CLF uptake, and mitochondrial-induced toxicity-Modeling CYP2C9*2 iPSC-liver organoids and susceptibility to bosentan-induced cholestasis. This evidence concerns the gene CYP2C9 and cholestasis.